Leishmania Antigens Are Presented to CD8+ T Cells by a Transporter Associated with Antigen Processing-Independent Pathway In Vitro and In Vivo

CD8+ T cells are generated in response to Leishmania major (Lm) or Toxoplasma gondii parasitic infections, indicating that exogenously delivered Ag can be processed for presentation by MHC class I molecules. We show that presentation of Lm nucleotidase (NT)-OVA is TAP independent in vivo and in vitro, and is inhibited by chloroquine, but not by proteasome inhibitors. In contrast, the presentation of T. gondii P30-OVA relies on the TAP/proteasome pathway. Presentation of OVA- or rNT-OVA-coated beads also bypassed TAP requirement above a certain Ag threshold. TAP was also dispensable for the presentation of wild-type Lm Ags to primed CD8+ T cells in vitro. Finally, in vivo priming of CD8+ T cells involved in acquired resistance to Lm was not compromised in TAP-deficient mice. Thus, Leishmania Ags appear to be confined to an intraphagosomal processing pathway that requires higher concentrations of Ags, suggesting that these parasites may have evolved strategies to impair the efficient endoplasmic reticulum-based, TAP-dependent cross-presentation pathway to avoid or delay CD8+ T cell priming.

[1]  J. Neefjes,et al.  The many roads to cross-presentation , 2005, The Journal of experimental medicine.

[2]  S. Grinstein,et al.  Quantitative and Dynamic Assessment of the Contribution of the ER to Phagosome Formation , 2005, Cell.

[3]  Y. Belkaid,et al.  Antigen Requirements for Efficient Priming of CD8+ T Cells by Leishmania major-Infected Dendritic Cells , 2005, Infection and Immunity.

[4]  N. Shastri,et al.  Class I Major Histocompatibility Complex Presentation of Antigens That Escape from the Parasitophorous Vacuole of Toxoplasma gondii , 2005, Infection and Immunity.

[5]  K. Rock,et al.  Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. , 2004, Immunity.

[6]  D. Tscharke,et al.  CD8+ T Cell Cross-Priming via Transfer of Proteasome Substrates , 2004, Science.

[7]  T. Cover,et al.  Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. , 2003, Blood.

[8]  R. Tampé,et al.  Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Davoust,et al.  ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells , 2003, Nature.

[10]  Etienne Gagnon,et al.  Phagosomes are competent organelles for antigen cross-presentation , 2003, Nature.

[11]  A. G. Grandea,et al.  Tapasin−/− and TAP1−/− Macrophages Are Deficient in Vacuolar Alternate Class I MHC (MHC-I) Processing due to Decreased MHC-I Stability at Phagolysosomal pH1 , 2003, The Journal of Immunology.

[12]  Y. Belkaid,et al.  CD8+ T Cells Are Required for Primary Immunity in C57BL/6 Mice Following Low-Dose, Intradermal Challenge with Leishmania major , 2002, The Journal of Immunology.

[13]  F. Lechner,et al.  Cross‐presentation of virus‐like particles by skin‐derived CD8– dendritic cells: a dispensable role for TAP , 2002, European journal of immunology.

[14]  S. Beverley,et al.  A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. , 2001, Experimental parasitology.

[15]  J. Yewdell,et al.  Multiple Antigen-Specific Processing Pathways for Activating Naive CD8+ T Cells In Vivo , 2001, The Journal of Immunology.

[16]  J. Yewdell,et al.  Cut and trim: generating MHC class I peptide ligands. , 2001, Current opinion in immunology.

[17]  E. Kominami,et al.  Generation of both MHC class I‐ and class II‐restricted antigenic peptides from exogenously added ovalbumin in murine phagosomes , 2000, FEBS letters.

[18]  Y. Belkaid,et al.  A Natural Model of Leishmania major Infection Reveals a Prolonged “Silent” Phase of Parasite Amplification in the Skin Before the Onset of Lesion Formation and Immunity , 2000, The Journal of Immunology.

[19]  L. Kaer,et al.  Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Cresswell Intracellular Surveillance: Controlling the Assembly of MHC Class I‐Peptide Complexes , 2000, Traffic.

[21]  Sebastian Amigorena,et al.  Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells , 1999, Nature Cell Biology.

[22]  J. Neefjes,et al.  Recycling MHC class I molecules and endosomal peptide loading. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Theander,et al.  Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major. , 1999, Clinical immunology.

[24]  Mattias Svensson,et al.  Classical MHC class I peptide presentation of a bacterial fusion protein by bone marrow‐derived dendritic cells , 1999, European journal of immunology.

[25]  C. Harding,et al.  Activation of Human CD8+ αβ TCR+ Cells by Mycobacterium tuberculosis Via an Alternate Class I MHC Antigen-Processing Pathway , 1999, The Journal of Immunology.

[26]  D. Roos,et al.  Expression, selection, and organellar targeting of the green fluorescent protein in Toxoplasma gondii. , 1998, Molecular and biochemical parasitology.

[27]  P. Ricciardi-Castagnoli,et al.  Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Albert,et al.  Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs , 1998, Nature.

[29]  A. Diehl,et al.  TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells. , 1997, Journal of immunology.

[30]  D. Mcmahon-Pratt,et al.  Presentation via the class I pathway by Leishmania amazonensis-infected macrophages of an endogenous leishmanial antigen to CD8+ T cells. , 1997, Journal of immunology.

[31]  D. Busch,et al.  MHC class I antigen processing of Listeria monocytogenes proteins: implications for dominant and subdominant CTL responses , 1997, Immunological reviews.

[32]  R. Kurlander,et al.  Characterization of the murine H2–M3wt‐restricted CD8 response against a hydrophobic, protease‐resistant, phospholipid‐associated antigen from Listeria monocytogenes , 1997, Immunological reviews.

[33]  J. Pfeifer,et al.  Major histocompatibility complex class I presentation of ovalbumin peptide 257–264 from exogenous sources: protein context influences the degree of TAP‐independent presentation , 1996, European journal of immunology.

[34]  K. Rock,et al.  Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C. Harding,et al.  Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. , 1996, Journal of immunology.

[36]  H. Dockrell,et al.  Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro , 1996, Immunology.

[37]  K. Heeg,et al.  Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway. , 1995, Immunology.

[38]  G. Splitter,et al.  CD8+ Type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I‐ and class II‐deficient mice , 1995, European journal of immunology.

[39]  J. Reimann,et al.  Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I‐restricted epitope presentation , 1995, European journal of immunology.

[40]  M. Kovacsovics-Bankowski,et al.  A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules , 1995, Science.

[41]  P. Romero,et al.  Leishmania major infection in mice primes for specific major histocompatibility complex class I‐restricted CD8+ cytotoxic T cell responses , 1994, European journal of immunology.

[42]  F. Conceição-Silva,et al.  Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis , 1994, Infection and immunity.

[43]  J. Pfeifer,et al.  Phagocytic processing of bacterial antigens for class I MHC presentation to T cells , 1993, Nature.

[44]  A. Sher,et al.  Bone marrow macrophages process exogenous Toxoplasma gondii polypeptides for recognition by parasite-specific cytolytic T lymphocytes. , 1993, Journal of immunology.

[45]  I. Müller Role of T cell subsets during the recall of immunologic memory to Leishmania major , 1992, European journal of immunology.

[46]  G. Griffiths,et al.  A T. cruzi-secreted protein immunologically related to the complement component C9: Evidence for membrane pore-forming activity at low pH , 1990, Cell.

[47]  R. Mshana,et al.  In Situ Characterization of the Cutaneous Immune Response in Ethiopian Cutaneous Leishmaniasis , 1987, Scandinavian journal of immunology.

[48]  K. Chang,et al.  Multiplication of a human parasite (Leishmania donovani) in phagolysosomes of hamster macrophages in vitro. , 1976, Science.

[49]  M. Bevan Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay , 1976, The Journal of experimental medicine.

[50]  L. Kaer,et al.  Macrophages Are Deficient in Vacuolar Alternate Class I MHC (MHC-I) Processing due to Decreased MHC-I Stability at Phagolysosomal pH , 2003 .

[51]  R. Andino,et al.  Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen , 1999, Nature.

[52]  C. Harding,et al.  Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. , 1999, Journal of immunology.

[53]  E. Jaffee,et al.  Bone marrow-derived cells present MHC class I-restricted tumour antigens in priming of antitumour immune responses. , 1994, Ciba Foundation symposium.

[54]  A. Sher,et al.  CD8+ T-cell interactions with Toxoplasma gondii: implications for processing of antigen for class-I-restricted recognition. , 1993, Research in immunology.

[55]  P. Vassalli,et al.  Involvement of specific Lyt‐2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis , 1987, European journal of immunology.